Compassionate use, also known as expanded access, refers to the provision of investigational medical treatments to patients with serious or life-threatening conditions, such as cancer, when no other treatments are available. This practice allows patients to access potentially beneficial treatments that are currently under clinical trial but not yet approved by regulatory authorities like the FDA.
